Suparma Tbk PT
IDX:SPMA

Watchlist Manager
Suparma Tbk PT Logo
Suparma Tbk PT
IDX:SPMA
Watchlist
Price: 304 IDR
Market Cap: 958.8B IDR
Have any thoughts about
Suparma Tbk PT?
Write Note

Intrinsic Value

The intrinsic value of one SPMA stock under the Base Case scenario is 627.4 IDR. Compared to the current market price of 304 IDR, Suparma Tbk PT is Undervalued by 52%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

SPMA Intrinsic Value
627.4 IDR
Undervaluation 52%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Suparma Tbk PT

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for SPMA cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about SPMA?
Bearish
Neutral
Bullish

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Suparma Tbk PT

Provide an overview of the primary business activities
of Suparma Tbk PT.

What unique competitive advantages
does Suparma Tbk PT hold over its rivals?

What risks and challenges
does Suparma Tbk PT face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Suparma Tbk PT.

Provide P/S
for Suparma Tbk PT.

Provide P/E
for Suparma Tbk PT.

Provide P/OCF
for Suparma Tbk PT.

Provide P/FCFE
for Suparma Tbk PT.

Provide P/B
for Suparma Tbk PT.

Provide EV/S
for Suparma Tbk PT.

Provide EV/GP
for Suparma Tbk PT.

Provide EV/EBITDA
for Suparma Tbk PT.

Provide EV/EBIT
for Suparma Tbk PT.

Provide EV/OCF
for Suparma Tbk PT.

Provide EV/FCFF
for Suparma Tbk PT.

Provide EV/IC
for Suparma Tbk PT.

Compare the intrinsic valuations
of Suparma Tbk PT and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Suparma Tbk PT against its competitors.

Analyze the profit margins
(gross, operating, and net) of Suparma Tbk PT compared to its peers.

Compare the P/E ratios
of Suparma Tbk PT against its peers.

Discuss the investment returns and shareholder value creation
comparing Suparma Tbk PT with its peers.

Analyze the financial leverage
of Suparma Tbk PT compared to its main competitors.

Show all profitability ratios
for Suparma Tbk PT.

Provide ROE
for Suparma Tbk PT.

Provide ROA
for Suparma Tbk PT.

Provide ROIC
for Suparma Tbk PT.

Provide ROCE
for Suparma Tbk PT.

Provide Gross Margin
for Suparma Tbk PT.

Provide Operating Margin
for Suparma Tbk PT.

Provide Net Margin
for Suparma Tbk PT.

Provide FCF Margin
for Suparma Tbk PT.

Show all solvency ratios
for Suparma Tbk PT.

Provide D/E Ratio
for Suparma Tbk PT.

Provide D/A Ratio
for Suparma Tbk PT.

Provide Interest Coverage Ratio
for Suparma Tbk PT.

Provide Altman Z-Score Ratio
for Suparma Tbk PT.

Provide Quick Ratio
for Suparma Tbk PT.

Provide Current Ratio
for Suparma Tbk PT.

Provide Cash Ratio
for Suparma Tbk PT.

What is the historical Revenue growth
over the last 5 years for Suparma Tbk PT?

What is the historical Net Income growth
over the last 5 years for Suparma Tbk PT?

What is the current Free Cash Flow
of Suparma Tbk PT?

Discuss the annual earnings per share (EPS)
trend over the past five years for Suparma Tbk PT.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Suparma Tbk PT

Current Assets 1.5T
Cash & Short-Term Investments 362.4B
Receivables 200B
Other Current Assets 907B
Non-Current Assets 1.9T
Long-Term Investments 30.6B
PP&E 1.9T
Other Non-Current Assets 15.9B
Current Liabilities 524.8B
Accounts Payable 111.8B
Accrued Liabilities 16.4B
Short-Term Debt 77.8B
Other Current Liabilities 318.8B
Non-Current Liabilities 508B
Long-Term Debt 264.8B
Other Non-Current Liabilities 243.2B
Efficiency

Earnings Waterfall
Suparma Tbk PT

Revenue
2.6T IDR
Cost of Revenue
-2.2T IDR
Gross Profit
451.5B IDR
Operating Expenses
-211.9B IDR
Operating Income
239.5B IDR
Other Expenses
-131.3B IDR
Net Income
108.3B IDR

Free Cash Flow Analysis
Suparma Tbk PT

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

SPMA Profitability Score
Profitability Due Diligence

Suparma Tbk PT's profitability score is 53/100. The higher the profitability score, the more profitable the company is.

Positive Free Cash Flow
Positive Gross Profit
Positive 3-Year Average ROE
Positive Operating Income
53/100
Profitability
Score

Suparma Tbk PT's profitability score is 53/100. The higher the profitability score, the more profitable the company is.

SPMA Solvency Score
Solvency Due Diligence

Suparma Tbk PT's solvency score is 53/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Negative Net Debt
53/100
Solvency
Score

Suparma Tbk PT's solvency score is 53/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

SPMA Price Targets Summary
Suparma Tbk PT

There are no price targets for SPMA.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for SPMA?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for SPMA is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Suparma Tbk PT Logo
Suparma Tbk PT

Country

Indonesia

Industry

Paper & Forest

Market Cap

958.8B IDR

Dividend Yield

3.95%

Description

PT Suparma Tbk engages in the manufacture and sale of paper and its related products. The company is headquartered in Surabaya, Jawa Timur and currently employs 779 full-time employees. The firm is engaged in the producing of quality paper and packaging paper products, which can be classified into two types: industrial and consumer. Its industrial paper products include duplex board, wrapping kraft, ribbed kraft, laminated kraft, samson kraft, base paper, and machine glazed paper. Its consumer paper products include tissue paper, towel paper, laminated wrapping craft, and laminated machine glazed paper. Its products are marketed under two brand names See-U and Plenty. The firm sells its products domestically and internationally.

Contact

JAWA TIMUR
Surabaya
Jl. Mastrip No.856, Karangpilang
+6231766666
ptsuparmatbk.com

IPO

1994-11-15

Employees

779

Officers

President Director
Mr. Edward Sopanan
Head of Internal Audit
Mr. Davin Otniel Tjoputro
Corporate Secretary & Independent Director
Mr. Hendro Luhur
Corporate Secretary
Ms. Alberta Angela

See Also

Discover More
What is the Intrinsic Value of one SPMA stock?

The intrinsic value of one SPMA stock under the Base Case scenario is 627.4 IDR.

Is SPMA stock undervalued or overvalued?

Compared to the current market price of 304 IDR, Suparma Tbk PT is Undervalued by 52%.

Back to Top